Multiparameter evidence synthesis in epidemiology and medical decision-making

Meta-analysis has been well-established for many years, but has been largely confined to pooling evidence on pair-wise contrasts. Broader forms of synthesis have also been described, apparently re-invented in disparate fields, each time taking different computational approaches. The potential value of Bayesian estimation of a joint posterior parameter distribution and simultaneously sampling from it for decision analysis has also been appreciated. However, applications have been relatively few in number, sometimes stylized, and presented mainly to a statistical methods audience. As a result, the potential for multiparameter evidence synthesis in both epidemiology and health technology assessment has remained largely unrecognized. The advent of flexible software for Bayesian Markov chain Monte Carlo in the shape of WinBUGS has the made these earlier strands of work more widely available. Researchers can now carry out synthesis at a realistic level of complexity. The Bristol programme has not only contributed to a growing body of literature on how to synthesize different evidence structures, but also on how to check the consistency of multiple information sources and how to use the resulting models to prioritize future research.

[1]  Mitchell J. Small,et al.  Updating Uncertainty in an Integrated Risk Assessment: Conceptual Framework and Methods , 1995 .

[2]  Roderick J. A. Little,et al.  Statistical Analysis with Missing Data: Little/Statistical Analysis with Missing Data , 2002 .

[3]  I Olkin,et al.  Re: "A critical look at some popular meta-analytic methods". , 1994, American journal of epidemiology.

[4]  I. Bruce,et al.  The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. , 2007, Rheumatology.

[5]  K R Abrams,et al.  Bayesian methods in meta-analysis and evidence synthesis. , 2001, Statistical methods in medical research.

[6]  A E Ades,et al.  Effect of the worldwide epidemic on HIV prevalence in the United Kingdom: record linkage in anonymous neonatal seroprevalence surveys. , 1999, AIDS.

[7]  A. Raftery,et al.  Inference for Deterministic Simulation Models: The Bayesian Melding Approach , 2000 .

[8]  V Hasselblad,et al.  Meta-analytic Tools for Medical Decision Making: A Practical Guide , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[9]  G. Lu,et al.  Combination of direct and indirect evidence in mixed treatment comparisons , 2004, Statistics in medicine.

[10]  Sylvia Richardson,et al.  Improving ecological inference using individual‐level data , 2006, Statistics in medicine.

[11]  J Lipscomb,et al.  Assessing Uncertainty in Cost-Effectiveness Analyses , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[12]  K Claxton,et al.  An economic approach to clinical trial design and research priority-setting. , 1996, Health economics.

[13]  M Sculpher,et al.  A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. , 2004, Health technology assessment.

[14]  Sander Greenland,et al.  Multiple‐bias modelling for analysis of observational data , 2005 .

[15]  Nick Black,et al.  The Cooksey review of UK health research funding , 2006, BMJ : British Medical Journal.

[16]  N. Welton,et al.  Estimation of Markov Chain Transition Probabilities and Rates from Fully and Partially Observed Data: Uncertainty Propagation, Evidence Synthesis, and Model Calibration , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[17]  Catherine H Mercer,et al.  Estimates of human immunodeficiency virus prevalence and proportion diagnosed based on Bayesian multiparameter synthesis of surveillance data , 2008 .

[18]  S D Walter,et al.  The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. , 1997, Journal of clinical epidemiology.

[19]  A E Ades,et al.  The Interpretation of Random-Effects Meta-Analysis in Decision Models , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[20]  C S Berkey,et al.  Multiple-outcome meta-analysis of clinical trials. , 1996, Statistics in medicine.

[21]  Wendy Macdowall,et al.  Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours , 2001, The Lancet.

[22]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[23]  Laura Bojke,et al.  Incorporating direct and indirect evidence using bayesian methods: an applied case study in ovarian cancer. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[24]  G. Lu,et al.  Assessing Evidence Inconsistency in Mixed Treatment Comparisons , 2006 .

[25]  Adrian E. Raftery,et al.  Probabilistic projections of HIV prevalence using Bayesian melding. , 2007, 0709.0421.

[26]  Kerrie Mengersen,et al.  Multivariate meta‐analysis , 2003, Statistics in medicine.

[27]  David J. Spiegelhalter,et al.  Conflicting evidence in a Bayesian synthesis of surveillance data to estimate human immunodeficiency virus prevalence , 2008 .

[28]  A E Ades,et al.  Estimating hepatitis C prevalence in England and Wales by synthesizing evidence from multiple data sources. Assessing data conflict and model fit. , 2008, Biostatistics.

[29]  A E Ades,et al.  Expected Value of Sample Information Calculations in Medical Decision Modeling , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.

[30]  Nicky J Welton,et al.  A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation. , 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[31]  Robert Schlaifer Student's manual for probability and statistics for business decisions , 1959 .

[32]  D. Spieglhalter,et al.  Bayesian methods in health technology assessment , 2000 .

[33]  David M. Eddy,et al.  Meta-analysis by the confidence profile method , 1992 .

[34]  Cross design synthesis: a new strategy for studying medical outcomes? , 1992, The Lancet.

[35]  C. Mercer,et al.  Estimating adult HIV prevalence in the UK in 2003: the direct method of estimation , 2006, Sexually Transmitted Infections.

[36]  Nicola J Cooper,et al.  Integration of Meta-analysis and Economic Decision Modeling for Evaluating Diagnostic Tests , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.

[37]  R. Wolpert,et al.  Combining Information From Related Regressions , 1997 .

[38]  R J Carroll,et al.  On meta-analytic assessment of surrogate outcomes. , 2000, Biostatistics.

[39]  Adrian E. Raftery,et al.  Inference from a Deterministic Population Dynamics Model for Bowhead Whales , 1995 .

[40]  K E Willard,et al.  Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation , 1986, Medical decision making : an international journal of the Society for Medical Decision Making.

[41]  Julian P T Higgins,et al.  Bayesian synthesis of epidemiological evidence with different combinations of exposure groups: application to a gene–gene–environment interaction , 2006, Statistics in medicine.

[42]  A E Ades,et al.  Markov Chain Monte Carlo Estimation of a Multiparameter Decision Model: Consistency of Evidence and the Accurate Assessment of Uncertainty , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

[43]  David W. Dilks,et al.  Development of Bayesian Monte Carlo techniques for water quality model uncertainty , 1992 .

[44]  Nicky J Welton,et al.  Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses , 2007, BMJ : British Medical Journal.

[45]  David R. Jones,et al.  Bayesian methods in health technology assessment: a review. , 2000, Health technology assessment.

[46]  Marek Ancukiewicz,et al.  Decision Models in Clinical Recommendations Development : the Stroke Prevention Policy , 1996 .

[47]  F Dominici,et al.  Combining Contingency Tables with Missing Dimensions , 2000, Biometrics.

[48]  D. Rubin,et al.  Statistical Analysis with Missing Data , 1988 .

[49]  David M. Eddy,et al.  The Confidence Profile Method: A Bayesian Method for Assessing Health Technologies , 1989, Oper. Res..

[50]  R. A. Doney,et al.  4. Probability and Random Processes , 1993 .

[51]  Eleanor Chelimsky,et al.  Cross design synthesis , 1993, The Lancet.

[52]  Anand Patwardhan,et al.  Bayesian Methods for Model Uncertainty Analysis with Application to Future Sea Level Rise , 1992 .

[53]  M. A. Best Bayesian Approaches to Clinical Trials and Health‐Care Evaluation , 2005 .

[54]  A Whitehead,et al.  Borrowing strength from external trials in a meta-analysis. , 1996, Statistics in medicine.

[55]  Nicholas J Wald,et al.  Teleoanalysis: combining data from different types of study , 2003, BMJ : British Medical Journal.

[56]  Deborah M Caldwell,et al.  Simultaneous comparison of multiple treatments: combining direct and indirect evidence , 2005, BMJ : British Medical Journal.

[57]  A E Ades,et al.  Correction: Interpretation of Random Effects Meta-analysis in Decision Models , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[58]  Deborah M Caldwell,et al.  Research prioritization based on expected value of partial perfect information: a case‐study on interventions to increase uptake of breast cancer screening , 2008 .

[59]  Giovanni Parmigiani,et al.  Meta-Analysis of Migraine Headache Treatments: Combining Information from Heterogeneous Designs , 1999 .

[60]  B. McNeil,et al.  Probabilistic Sensitivity Analysis Using Monte Carlo Simulation , 1985, Medical decision making : an international journal of the Society for Medical Decision Making.

[61]  Nicky J Welton,et al.  A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence , 2005 .

[62]  John Ioannidis,et al.  Exploring the Geometry of Treatment Networks , 2008, Annals of Internal Medicine.

[63]  K. Abrams,et al.  Bayesian implementation of a genetic model‐free approach to the meta‐analysis of genetic association studies , 2005, Statistics in medicine.

[64]  Geof H. Givens,et al.  Logarithmic Pooling of Priors Linked by a Deterministic Simulation Model , 1999 .

[65]  David J Spiegelhalter,et al.  Bias modelling in evidence synthesis , 2009, Journal of the Royal Statistical Society. Series A,.

[66]  Georgia Salanti,et al.  Evaluation of networks of randomized trials , 2008, Statistical methods in medical research.

[67]  R. T. Birge Probable Values of e, h, em, and α , 1932 .

[68]  Lex M Bouter,et al.  Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses. , 2004, International journal of epidemiology.

[69]  Nicky J Welton,et al.  Allowing for uncertainty due to missing data in meta‐analysis—Part 2: Hierarchical models , 2008, Statistics in medicine.

[70]  D. De Angelis,et al.  An evidence synthesis approach to estimating Hepatitis C Prevalence in England and Wales , 2009, Statistical methods in medical research.

[71]  S. Sharp,et al.  Explaining heterogeneity in meta-analysis: a comparison of methods. , 1999 .

[72]  A E Ades,et al.  A chain of evidence with mixed comparisons: models for multi‐parameter synthesis and consistency of evidence , 2003, Statistics in medicine.

[73]  T. Colbourn,et al.  Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses. , 2007, Health technology assessment.

[74]  Geert Molenberghs,et al.  Statistical challenges in the evaluation of surrogate endpoints in randomized trials. , 2002, Controlled clinical trials.

[75]  M J Daniels,et al.  Meta-analysis for the evaluation of potential surrogate markers. , 1997, Statistics in medicine.

[76]  A E Ades,et al.  Meta‐analysis of mixed treatment comparisons at multiple follow‐up times , 2007, Statistics in medicine.

[77]  David R. Jones,et al.  Hierarchical models in generalized synthesis of evidence: an example based on studies of breast cancer screening. , 2000, Statistics in medicine.

[78]  Susan R. Wilson,et al.  Bayesian projection of the acquired immune deficiency syndrome epidemic , 2002 .

[79]  K Claxton,et al.  The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.

[80]  Anthony O'Hagan,et al.  Calculating Partial Expected Value of Perfect Information via Monte Carlo Sampling Algorithms , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[81]  J Lipscomb,et al.  Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke. , 1999, Journal of clinical epidemiology.

[82]  Gordon B. Hazen,et al.  Sensitivity Analysis and the Expected Value of Perfect Information , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[83]  R. Spear Eutrophication in peel inlet—II. Identification of critical uncertainties via generalized sensitivity analysis , 1980 .